As of January 22, 2025, Portage Biotech (PRTG) has a market cap of $4.596 million USD. According to our data, Portage Biotech is ranked No.9067 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $4.60 M |
-20.70%
|
Dec 31, 2024 | $5.80 M |
-85.80%
|
Dec 29, 2023 | $40.81 M |
-65.59%
|
Dec 30, 2022 | $0.12 B |
-50.71%
|
Dec 31, 2021 | $0.24 B |
-45.23%
|
Dec 31, 2020 | $0.44 B |
108.40%
|
Dec 31, 2019 | $0.21 B |
-2.08%
|
Dec 31, 2018 | $0.22 B |
-83.59%
|
Dec 29, 2017 | $1.31 B |
350.00%
|
Dec 30, 2016 | $0.29 B |
-0.76%
|
Dec 31, 2015 | $0.29 B |
-2.96%
|
Dec 31, 2014 | $0.30 B |
-28.95%
|
Dec 31, 2013 | $0.43 B |
171.43%
|
Dec 31, 2012 | $0.16 B |
75.00%
|
Dec 30, 2011 | $89.68 M |
-78.95%
|
Dec 31, 2010 | $0.43 B |
-39.68%
|
Dec 31, 2009 | $0.71 B |
186.36%
|
Dec 31, 2008 | $0.25 B |
-60.71%
|
Dec 31, 2007 | $0.63 B |
3.70%
|
Dec 29, 2006 | $0.61 B |
12.50%
|
Dec 30, 2005 | $0.54 B |
-85.88%
|
Dec 31, 2004 | $3.81 B |
68.32%
|
Dec 31, 2003 | $2.26 B |
140.48%
|
Dec 31, 2002 | $0.94 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Market Cap | = | PRTG Stock Price | * | PRTG Shares Outstanding |
= | $4.10 | * | 1.12 M | |
= | $4.60 M |